MAPT and Alzheimer disease: To experimentally test whether CMA deficiency, as the one observed in AD patients, increases tau spreading in vivo, we took advantage of a recently developed adeno-associated virus (AAV) expressing green fluorescent protein (GFP)-2a-human tau (huTau)58,59 that generates equimolar amounts of GFP and human tau upon self-cleavage.